Stock CYTT CYTEIR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Cyteir Therapeutics, Inc.

Equities

CYTT

US23284P1030

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Morgan Stanley Downgrades Cyteir Therapeutics to Underweight From Equal Weight, Adjusts Price Target to $2 From $4
MT
BofA Securities Downgrades Cyteir Therapeutics to Neutral From Buy, Adjusts Price Target to $2 From $4
MT
Wedbush Lowers Cyteir Therapeutics' Price Target to $3 From $8, Notes 'Disappointing' Monotherapy Results; Keeps Outperform Rating
MT
JPMorgan Downgrades Cyteir Therapeutics to Neutral From Overweight
MT
Wedbush Lowers Cyteir Therapeutics' PT to $8 From $13, Adjusts Expectations Around Future Equity Raises in Model; Keeps Outperform Rating
MT
Morgan Stanley Downgrades Cyteir Therapeutics to Equalweight From Overweight, Cuts Price Target to $4 From $14
MT
Wedbush Adjusts Price Target on Cyteir Therapeutics to $13 From $17, Keeps Outperform Rating
MT
Wedbush Adjusts Cyteir Therapeutics' Price Target to $17 From $30, Citing Future Equity Financings, CYT-0851 Mechanism Update; Outperform Rating Kept
MT
Wedbush Adjusts Cyteir Therapeutics' Price Target to $30 From $40, Citing Future Equity Raises; Outperform Rating Kept
MT
Northland Starts Cyteir Therapeutics at Outperform With $16 Price Target
MT
CYTEIR THERAPEUTICS : Wedbush Starts Cyteir Therapeutics at Outperform With $40 Price Target
MT
CYTEIR THERAPEUTICS : Morgan Stanley Starts Cyteir Therapeutics at Overweight With $33 Price Target
MT
CYTEIR THERAPEUTICS : BofA Securities Starts Cyteir Therapeutics at Buy With $23 Price Target
MT
CYTEIR THERAPEUTICS : JPMorgan Starts Cyteir Therapeutics at Overweight With $30 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYTT Stock
  4. News Cyteir Therapeutics, Inc.
  5. Analyst Reco.